Warning: This security is no longer trading.
Eli Lilly and Company announced the successful completion of its acquisition of ARMO BioSciences, Inc.
ARMO BioSciences, Inc. (ARMO): Price and Financial Metrics
GET POWR RATINGS... FREE!
ARMO Stock Price Chart Interactive Chart >
ARMO Price/Volume Stats
| Current price | $49.98 | 52-week high | $57.19 |
| Prev. close | $49.97 | 52-week low | $25.10 |
| Day low | $49.96 | Volume | 297,400 |
| Day high | $50.01 | Avg. volume | 334,798 |
| 50-day MA | $41.04 | Dividend yield | N/A |
| 200-day MA | $0.00 | Market Cap | 1.52B |
ARMO BioSciences, Inc. (ARMO) Company Bio
ARMO BioSciences, Inc., an immuno-oncology company, develops a pipeline of novel product candidates that activate the immune system of cancer patients to recognize and eradicate tumors in the United States. Its lead product candidate includes AM0010, a drug that is in Phase III randomized pivotal clinical trial for the treatment of pancreatic ductal adenocarcinoma and chemotherapy. The company was formerly known as Targenics, Inc. and changed its name to ARMO BioSciences, Inc. in December 2012. ARMO BioSciences, Inc. was founded in 2010 and is based in Redwood City, California.
ARMO Price Returns
| 1-mo | N/A |
| 3-mo | N/A |
| 6-mo | N/A |
| 1-year | N/A |
| 3-year | N/A |
| 5-year | N/A |
| YTD | N/A |
| 2022 | N/A |
| 2021 | N/A |
| 2020 | N/A |
| 2019 | N/A |
| 2018 | N/A |
Loading social stream, please wait...